We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-18.82%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.03B
AUM Growth
-$200M
Cap. Flow
+$16M
Cap. Flow %
1.55%
Top 10 Hldgs %
58.26%
Holding
811
New
317
Increased
98
Reduced
90
Closed
269

Top Buys

Rank Stock Value
1
VAL icon
Valaris
VAL
+$24.3M
2
MRNA icon
Moderna
MRNA
+$9.63M
3
SLV icon
iShares Silver Trust
SLV
+$9.23M
4
TMUS icon
T-Mobile US
TMUS
+$9.02M
5
NE icon
Noble Corp
NE
+$6.74M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$107M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29M
3
APTV icon
Aptiv
APTV
+$22.6M
4
MSFT icon
Microsoft
MSFT
+$20.8M
5
AMZN icon
Amazon
AMZN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Consumer Discretionary 12.31%
3 Materials 12.15%
4 Industrials 5.19%
5 Financials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGVC icon
476
Vitamin Cottage Natural Grocers
NGVC
$605M
$182K 0.02%
11,399
-781
-6% -$14.5K
OSPN icon
477
OneSpan
OSPN
$603M
$175K 0.02%
14,674
– –
CONN
478
DELISTED
Conn's Inc.
CONN
$173K 0.02%
+21,592
New +$284K
APLE icon
479
Apple Hospitality REIT
APLE
$3.71B
$171K 0.02%
11,668
-1,255
-10% -$20.8K
MTRX icon
480
Matrix Service
MTRX
$326M
$168K 0.02%
33,216
– –
DAKT icon
481
Daktronics
DAKT
$1.03B
$162K 0.02%
53,890
– –
WW
482
DELISTED
WW International
WW
$160K 0.02%
+25,040
New +$211K
MDRX
483
DELISTED
Veradigm Inc. Common Stock
MDRX
$159K 0.02%
10,752
-1,147
-10% -$21.4K
DOYU
484
DouYu International Holdings
DOYU
$134M
$158K 0.02%
13,189
– –
GOOGL icon
485
Alphabet (Google) Class A
GOOGL
$4.37T
$153K 0.01%
1,400
– –
MFA
486
MFA Financial
MFA
$919M
$149K 0.01%
13,874
+5,118
+58% +$68.9K
PSNL icon
487
Personalis
PSNL
$1.55B
$146K 0.01%
42,375
+9,113
+27% +$46.4K
TRUE
488
DELISTED
TrueCar
TRUE
$141K 0.01%
54,331
– –
ALLK
489
DELISTED
Allakos
ALLK
$139K 0.01%
44,396
+27,845
+168% +$104K
PR
490
Permian Resources
PR
$17.8B
$139K 0.01%
23,226
-41,260
-64% -$330K
VERU icon
491
Veru
VERU
$44.5M
$138K 0.01%
+1,222
New +$142K
INN
492
Summit Hotel Properties
INN
$670M
$137K 0.01%
+18,839
New +$166K
LE icon
493
Lands' End
LE
$402M
$137K 0.01%
+12,914
New +$169K
EOLS icon
494
Evolus
EOLS
$500M
$136K 0.01%
11,719
– –
VRA icon
495
Vera Bradley
VRA
$96.4M
$136K 0.01%
+31,258
New +$191K
DHC
496
Diversified Healthcare Trust
DHC
$2.04B
$134K 0.01%
73,512
+28,288
+63% +$64.7K
LTRX icon
497
Lantronix
LTRX
$256M
$134K 0.01%
24,831
-7,430
-23% -$42.9K
TEVA icon
498
Teva Pharmaceuticals
TEVA
$42.1B
$134K 0.01%
+17,834
New +$155K
PNTG icon
499
Pennant Group
PNTG
$1.38B
$132K 0.01%
10,332
-1,364
-12% -$22.7K
ASC icon
500
Ardmore Shipping
ASC
$670M
$126K 0.01%
+18,136
New +$121K
18 19
20
21 22

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Caxton Associates (New York) held 811 positions worth $1.03B, down 16% from $1.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Caxton Associates (New York)'s Q2 2022 filing shows 317 new, 98 increased, 90 reduced and 269 closed positions. Its largest new stake was Valaris: 451,426 shares worth $19.1M. The largest sale was Tesla, an estimated $107M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Caxton Associates (New York)'s largest Q2 2022 buy was Valaris: 451,426 shares worth $19.1M.
  • Caxton Associates (New York) added most to Moderna in Q2 2022, an estimated $9.63M increase.
  • Caxton Associates (New York)'s biggest Q2 2022 reduction was Aptiv, cutting an estimated $22.6M.
  • Caxton Associates (New York) fully exited Tesla in Q2 2022, selling an estimated $107M.
  • Caxton Associates (New York)'s ten largest holdings make up 58% of its $1.03B portfolio in Q2 2022.
  • Caxton Associates (New York) opened 317 new positions and closed 269 in Q2 2022.
  • Caxton Associates (New York)'s portfolio value fell 16% quarter-over-quarter to $1.03B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.